Oxidative stress induced by bloodless limb surgery on humans

European Journal of Clinical Investigation

Volumn 27, Issue 12, 1997, Pages 984-991

  Karg, E ^a,b   Nemeth I ^a   Virag, G ^b   Meszaros T ^b   Boda, D ^a   Pinter S ^b  

^a Department of Pediatrics ^*  (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Glutathione redox ratio; Ischaemia reperfusion,; Xanthine dehydrogenase; Xanthine oxidase

Indexed keywords

GLUTATHIONE; HEMOGLOBIN; HYPOXANTHINE; METHEMOGLOBIN; URIC ACID; XANTHINE; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMOLYSIS; HUMAN; HUMAN TISSUE; KNEE SURGERY; LIMB ISCHEMIA; ORTHOPEDIC SURGERY; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION; SYSTEMIC CIRCULATION;

EID: 0031437570     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.2130768.x     Document Type: Article

References (44)

1. Granger ND, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981 ;81:22-9.
2. McCord JM. Free radicals and myocardial ischemia: an overview and outloook. Free Rad Biol Med 1988;4:9-14.
3. Freeman BA, Crapo JD. Biology of disease. Free radicals and tissue injury. Lab Invest 1982;47:412-26.
4. Friedl HP, Smith DJ, Till GO, Thompson PD, Louis DS, Ward PA. Ischemia-reperfusion in humans. Am J Pathol I990;136:491-5.
5. Pétrone WF, English DK, Wong K, McCord JM. Free radicals and inflammation: The Superoxide dependent activation of neutrophil chemotactic factor in plasma. Proc Natl Acad Sci USA 1980;77:1159-116.
6. Tan S, Yokoyama Y, Dickens E, Cash TG, Freeman BA, Parks DA. Xanthine oxidase activity in the circulation of rats following hemoirhagic shock. Free Rad Biol Med 1993;15:407-14.
7. Saugstadt OD. Hypoxanthine as an indicator of hypoxia: Its role in health and disease through free radical production. Pediatr Res 1988:23:143-50.
8. Becker BF. Towards the physiological functions of uric acid. Free Rad Biol Med 1993:14:615-31.
9. Tan S, Radi R, Gaudier F et al. Physiologic levels of uric acid inhibit xanthine oxidase in human plasma. Pediatr Res 1993:34:303-7.
10. Van Asbeck BS, Hoidal J, Vercellotti GM, Schwanz BA, Moldow ChF, Jacob HS. Protection against lethal hyperoxia by tracheal insufflation of erythrocytes: Role of red cell glutathione. Science 1985;227:756-8.
11. Siems W, Mueller M, Garbe S, Gerber G. Damage of erythrocytes by activated oxygen generated in hypoxic rat liver. Free Rad Res Commun 1987;4:31-39.
12. Clahsen PC, Moison RMW, Holtzer CAJ, Berger HM. Recycling of glutathione during oxidative stress in erythrocytes of the newborn. Pediatr Res 1992;32:399-402.
13. Dubois-Rande JL, Artigou JY, Darmon JY et al. Oxidative stress in patients with unstable angina. Eur Heart J 1994;15:179-83.
14. Duthie GG, Robertson JD, Maughan RJ, Morrice PC. Blood antioxidant status and erythrocyte lipid peroxidation following distance running. Arch Biochem Biophys 1990;282:78-83.
15. Nemeth I, Boda D. Blood glutathione redox ratio as a parameter of oxidative stress in premature infants with IRDS. Free Rad Biol Med 1994:16:347-53.
16. Laaksonen DE, Atalay M, Niskanen L, Uusitupa M, Hanninen O, Sen CK. Increased resting and exercise-induced oxidative stress in young IDDM men. Diabetes Care 1996; 19:569-74.
17. Mathru M, Dries DJ, Barnes L;Tonino P, Sukhani R, Rooney MW. Tourniquet-induced exsanguination in patients requiring lower limb surgery. An ischemia-reperfusion model of oxidant and antioxidant metabolism. Anesthesiology 1996:84:14-22.
18. Ramboer CRH. A sensitive and nonradioactive assay for serum and tissue xanthine oxidase. J Lab Clin Med 1969:74:828-35.
19. Terada LS, Willingham IR, Rosandich ME, Leff JA, Kindt GW, Repine JE. Generation of Superoxide anion by brain endothelial cell xanthine oxidase. J Cell Physiol 1991;I48:191-6.
20. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with Polin phenol reagent. J Biol Chem 1951:193:265-75.
21. Harkness RA, Simmomds RJ, O'ConnorMC, Webster ADB. Purine metabolism studied with high-pressure liquid chromatography. Biochem Soc Trans 1979;7:102I-2.
22. Szebeni J, Winterbourn CC, Carrell RW. Oxidative interactions between hemoglobin and membrane lipid. A liposome model. Biochem J 1984;220:685-92.
23. Schoenberg MH, Fredholm BB, Hohlbach G. Changes in acid-base status, lactate concentration and purine metabolites during reconstructive aortic surgery. Acta Chir Scand I985;151:227-33.
24. Yokoyama Y, Beckman JS, Beckman TK el al. Circulating xanthine oxidase: Potential mediator of ischémie injury. Am J Physiol 1990;258:G564-70.
25. Tan S, Gelman S, Wheat JK, Parks DA. Circulating xanthine oxidase in human ischemia reperfusion. South Med J 1995;88:479-82.
26. Krenitsky TA, Tuttle JV, Cattau EL, Wang PA. A comparison of the distribution and electron acceptor specificities of xanthine oxidase and aldehyde oxidase. Comp Biochem Physiol 1974;49B:687-703.
27. Podzuwiet T, Beck H, Muller A et al. Absence of detectable xanthine oxidase in the human myocardium. Cardiovasc Res 1991;258:820-30.
28. Grum CM, Ragsdale RA, Ketai LH, Schlafer M. Absence of xanthine oxidase or xanthine dehydrogenase in the rabbit myocardium. Biochem Biophys Res Commun 1986;141:1104-8.
29. Wajner M, Harkness RA. Distribution of xanthine dehydrogenase and xanthine oxidase activities in human and rabbit tissue. Biochim Biophys Acta 1989;991:79-84.
30. Terada LS. Suppression of rabbit myocardial xanthine dehydrogenase activity by an endogenous compound. J Mol Cell Cardiol 1994:26:125-32.
31. Bray RC. The chemistry of xanthine oxidase. 6. Variations in stability and the presence of an inhibitor in certain preparations. Biochem J 1959;73:690-4.
32. Nielsen VG, Weinbroum A, Tan S, Samuelson PN, Gelman S, Parks DA. Xanthine oxidoreductase release after descending thoracic aorta occlusion and reperfusion in rabbits. J Thorac Cardiovasc Surg 1994;107:1222-7.
33. Adachi T, Fukushima T, Usami Y, Hirano K. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem J 1993:289:523-7.
34. Hiebert LM, Liu L. Héparine protects cultured endothelial cells from damage by toxic oxygen metabolites. Atherosclerosis 1991:83:47-51.
35. Tyrrell DJ, Kilfeather S, Page CP. Therapeutic uses of heparin beyond its traditional role as an anticoagulator. Trends Pharmacol Sci 1995:16:198-204.
36. Ley K, Cerrito M, Arfors K-E. Sulphated polysaccharides inhibit leukocyte rolling in rabbit mesentery venules. Am J Physiol 1991:260:1667-73.
37. Terada LS, Hybertson BM, Connelly KG, Weill D, Piermattei D, Repine JE. XO increases neutrophil adherence to endothelial cells by a dual ICAM-1 and P-selectin-mediated mechanism. J Appl Physiol 1997:82:866-73.
38. Nelson RM, Cecconi O, Roberts WG, Aruffo A, Linhardt RJ, Bevilacqua MP. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood 1993:82:3253-8.
39. Bazzoni G, Bettran Nunez A, Mascellani G, Bianchini P, Dejana E, Del Maschio A. Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocytes functions. J Lab Clin Med 1993:121:268-75.
40. Cerletti C, Rajtar G, Marchi E, de Gaetano G. Interactions between glycosaminoglycans, platelets and leukocytes. Semin Thromb Haemostasis 1994:20:245-53.
41. Tarantula M, Motterlini R, Beretta M, Saniaj M. Dual role of hypoxanthine in the reoxygenation of hypoxic isolated rat hearts. J Mol Cell Cardiol 1991;23:77-82.
42. Semb AG, Vaage J, Sorlie D, Lie M, Mjos OD. Coronary trapping of a complement activation product (C3a des-Arg) during myocardial reperfusion in open-heart surgery. Scand J Thorac Cardiovasc Surg 1990;24:223-227.
43. Formigli L, Lombardo LD, Adembri C, Brunelleschi S, Ferrari E, Novelll GP. Neutrophils as mediators of human skeletal muscle ischemia-reperfusion syndrome. Hum Pathol 1992;23:627-634.
44. Bishop MJ, Giclsa PC, Guidotti SM, Su ML, Chi EY. Complement activation is a secondary rather than causative factor in rabbit pulmonary artery ishemia-reperfusion injury. Am Rev Respir Dis 1991:143:386-90.